Cytomegalovirus Retinitis Completed Phase 3 Trials for Sargramostim (DB00020)

Also known as: CMV retinitis / Cytomegaloviral retinitis (disorder) / Cytomegalovirus chorioretinitis / Chorioretinitis caused by Cytomegalovirus (disorder)

IndicationStatusPhase
DBCOND0000283 (Cytomegalovirus Retinitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002070Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV RetinitisTreatment